1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Magnesium isoglycyrrhizinate: new trials by email Literature Review of Magnesium isoglycyrrhizinate trials Research Report on Magnesium isoglycyrrhizinate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia Methylprednisolone, Magnesium isoglycyrrhizinate, Glutathione - Drug Induced Liver Injury | Not applicable | Recruiting | General Hospital of Shenyang Military Region | 232 | 2025-06-24 | 2025-12-18 |
| Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B Entecavir, Magnesium Isoglycyrrhizinate, Diammonium Glycyrrhizinate - Chronic Hepatitis b, Liver Inflammation | Phase 4 | Unknown | Cttq | 480 | 2017-11-25 | 2017-11-21 |
Chemical and Drug Induced Liver Injury (1) · Hepatitis (1) · Hepatitis B, Chronic (1) · Hyperbilirubinemia (1) · Liver Cirrhosis (1) · Liver Failure (1)
Cttq (1) · General Hospital of Shenyang Military Region (1)
China (1)
Fengmei Wang (1) · Lu Zhou (1) · Qing Ye (1) · Weifen Xie (1) · Xin Zeng (1) · Xingshun Qi (1) · Yanjing Gao (1)
PMID 22806342, PMID 27426618, PMID 38402364, PMID 39183394, PMID 42080196